Massachusetts Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.7M	Sell	1,019,824 -52,659	-5%	-$1.26M	0.01%	615
2025 Q4	$28.6M	Sell	1,072,483 -38,243	-3%	-$914K	0.01%	586
2025 Q3	$23.7M	Buy	1,110,726 +1,052,038	+1,793%	+$24.9M	0.01%	607
2025 Q2	$1.27M	Buy	58,688 +725	+1%	+$13.5K	﹤0.01%	798
2025 Q1	$963K	Sell	57,963 -1,320	-2%	-$24K	﹤0.01%	810
2024 Q4	$1.09M	Sell	59,283 -1,768	-3%	-$28.5K	﹤0.01%	814
2024 Q3	$939K	Sell	61,051 -1,479	-2%	-$24.7K	﹤0.01%	801
2024 Q2	$1.02M	Buy	62,530 +2,100	+3%	+$33.9K	﹤0.01%	798
2024 Q1	$1.12M	Sell	60,430 -134	-0.2%	-$3.32K	﹤0.01%	780
2023 Q4	$1.9M	Buy	+60,564	New	+$1.45M	﹤0.01%	729
2018 Q2	–	Sell	-248,233	Closed	-$5.58M	–	839
2018 Q1	$5.58M	Buy	248,233 +66,283	+36%	+$1.84M	﹤0.01%	658
2017 Q4	$5.48M	Buy	181,950 +2,414	+1%	+$77.2K	﹤0.01%	659
2017 Q3	$6.76M	Buy	179,536 +1,096	+0.6%	+$35.7K	﹤0.01%	643
2017 Q2	$4.98M	Sell	178,440 -35	-0%	-$1.04K	﹤0.01%	673
2017 Q1	$6.14M	Sell	178,475 -266	-0.1%	-$9.39K	﹤0.01%	636
2016 Q4	$5.16M	Sell	178,741 -429	-0.2%	-$11.3K	﹤0.01%	658
2016 Q3	$5.7M	Sell	179,170 -59,517	-25%	-$2.02M	﹤0.01%	634
2016 Q2	$7.75M	Buy	238,687 +42,720	+22%	+$1.43M	﹤0.01%	599
2016 Q1	$5.48M	Buy	+195,967	New	+$4.27M	﹤0.01%	632